Adjuvant systemic therapy: State of the art, 1989 I. Craig Henderson 11th San Antonio Breast Cancer Symposium lecture Pages: 3 - 22
Chemoprevention of breast cancer Trevor J. PowlesJanet R. HardyJennifer G. Treleaven 11th San Antonio Breast Cancer Symposium Pages: 23 - 31
Megestrol acetate in breast cancer — A panel discussion William L. McGuirePatricia A. JohnsonC. Kent Osborne Viewpoints Pages: 33 - 38
Heritability of breast cancer and its role in pre-menopausal cases F. J. H. SluijterJ. W. KotenW. Den Otter Comment Pages: 39 - 41
Hormone prevention of mammary carcinogenesis by norethynodrel-mestranol Irma H. RussoJames FrederickJose Russo Report Pages: 43 - 56
Genomic DNA analysis of the estrogen receptor gene in breast cancer Fritz F. ParlDouglas R. CavenerWilliam D. Dupont Report Pages: 57 - 64
Antiestrogenic properties of keoxifene,trans-4-hydroxytamoxifen, and ICI 164384, a new steroidal antiestrogen, in ZR-75-1 human breast cancer cells Richard PoulinYves MerandFernand Labrie Report Pages: 65 - 76
Prognostic value of epidermal growth factor receptor in node-positive breast cancer M. GrimauxS. RomainH. Magdelénat Report Pages: 77 - 90
Inter- and intraobserver variability in the histopathological diagnosis of medullary carcinoma of the breast, and its prognostic implications Lise PedersenSusanne HolckHenning T. Mouridsen Report Pages: 91 - 99
Histone acetylation decreased by estradiol in the MCF-7 human mammary cancer cell line J. R. PasqualiniP. MercatN. Giambiagi Brief communication Pages: 101 - 105